As a leading international clinical and commercial manufacturer of biologics and pharmaceuticals focusing on gene therapies, advanced protein therapeutics, vaccines and cell therapies, NorthX Biologics (NXBio) offers a broad range of integrated and stand-alone development services, stretching from cell line development through to the commercial supply of investigational medicinal products. We take pride in manufacturing excellence and being a trusted provider and collaboration partner delivering what we promise and helping our customers to develop drugs for the benefit of patients.
Helena on her first day !
The world’s leading expo in the life sciences BIO-Europe will host its first in-person edition since 2019 in Leipziger Messe on 24 – 26 October.
Chetan is attending the Meeting on the Mesa event. Come and meet us !
NorthX Biologics (“NorthX”) styrelse har utsett Helena Strigård till ny vd. Hon kommer närmast från rollen som vd för branschorganisationen SwedenBIO. Helena kommer att leda NorthX fortsatta expansion av avancerad utveckling och produktion av biologiska läkemedel. Ted Fjällman, vd i NorthX och partner i huvudägaren Flerie Invest, fortsätter som ledamot i styrelsen.
MATFORS, Sweden, September 20, 2022 - The Board of NorthX Biologics ("NorthX") has appointed Helena Strigård as the new CEO. She joins NorthX from her role as Director General for the Swedish life science industry organization, SwedenBIO. Helena will lead NorthX's continued expansion in the development and production of advanced biologics. Ted Fjällman, current CEO of NorthX and Partner of the Company’s main investor, Flerie Invest, will continue to support the company as a member of the Board.
Please register to the seminar "Drug Development of Today and the Future" on the 19th of October!
Meeting on the mesa Carlsbad CA
NorthX Biologics appoints industry veterans to its board of directors
Idag kan vi meddela att vi expanderar inom produktion av cellterapi bl.a. via partnerskap med Alder Therapeutics samt att vi expanderar med en andra tillverkningsanläggning på Karolinska.
June 13-16, 2022・San Diego, CA
We are excited to be exhibiting at BIO USA this year. Come stop by our booth (#1054) or contact us to schedule a meeting.
Currently, mRNA medicines, such as vaccines, require freezers that can maintain −80 °C for large-scale handling and distribution. A new project has now started, with an aim to develop production processes for manufacturing mRNA medicines that remain stable even at 4 °C or higher. - The goal is to develop a dry vaccine, which would open up completely new opportunities for handling and distribution, says Randi Nordström, a researcher in formulation development at RISE.
Nordic Life Science Days (nlsd) is the largest Nordic partnering conference dedicated to the life science industry. The event attracts leading decision makers from biotech, pharma and med tech, as well as finance, research, policy and regulatory authorities.
The world tour is back! With more ’world leading’ activities within ATMP, highlighting and discussing the partnerships, infrastructures and competences critical to successes in our field.